Results 281 to 290 of about 3,117,738 (383)

Altered Expression of the ERM Proteins in Lung Adenocarcinoma [PDF]

open access: bronze, 2000
Masahide Tokunou   +5 more
openalex   +1 more source

TRIM38 Suppresses the Progression of Colorectal Cancer via Enhancing CCT6A Ubiquitination to Inhibit the MYC Pathway

open access: yesAdvanced Science, Volume 12, Issue 16, April 24, 2025.
This study reveals the tumor‐suppressive role of TRIM38 in colorectal cancer (CRC). TRIM38 is downregulated through DNA hypermethylation and correlates with unfavorable clinical features and poor prognosis. Mechanistically, TRIM38 inhibits CRC progression by promoting K48‐linked ubiquitination of CCT6A, leading to the destabilization of c‐Myc.
Yue Zhang   +10 more
wiley   +1 more source

Transition from Squamous Cell Carcinoma to Adenocarcinoma in Adenosquamous Carcinoma of the Lung [PDF]

open access: bronze, 2000
Hironobu Kanazawa   +7 more
openalex   +1 more source

Phosphorylation of POU3F3 Mediated Nuclear Translocation Promotes Proliferation in Non‐Small Cell Lung Cancer through Accelerating ATP5PF Transcription and ATP Production

open access: yesAdvanced Science, Volume 12, Issue 13, April 3, 2025.
POU3F3 is significantly upregulated in non‐small cell lung cancer (NSCLC). Activated ERK1 directly interacts with and phosphorylates POU3F3, facilitating its nuclear translocation in NSCLC cells. Within the nucleus, POU3F3 functions as a transcription factor to enhance ATP5PF expression, thereby increasing the activity of mitochondrial complex V and ...
Qi‐Gang Zeng   +14 more
wiley   +1 more source

Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab. [PDF]

open access: yesTher Adv Med Oncol, 2021
Saltman DL   +10 more
europepmc   +1 more source

Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS‐mutant Nonsmall Cell Lung Cancer

open access: yesAdvanced Science, Volume 12, Issue 15, April 17, 2025.
Embelin cotargets SHP2 to disrupt the SHP2/GRB2/SOS complex, inhibiting cancer‐related signaling pathways such as MAPK, (PI3K)/AKT pathway, and XIAP to induce apoptosis signaling pathway, respectively, leading to synthetic lethality in KRAS‐mutant NSCLC cells both in vivo and in vitro.
Nai‐jie Fu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy